BioMedSA’s Board of Directors approved 3 new memberships in February 2026: Cardivox AI, Joeris General Contractors, and TruCells.
Cardivox AI is developing an AI‑driven platform designed to analyze cardiovascular health using ECG and heart‑rate data. The system incorporates machine‑learning algorithms to estimate metrics such as blood pressure and identify potential cardiac risks. It integrates with third‑party tracking devices, processes collected health parameters through a cloud‑based infrastructure and provides results via web and mobile applications. This platform is intended for consumers seeking personalized health insights as well as healthcare professionals requiring data‑supported assessments. The company’s technology focuses on enabling scalable monitoring and supporting clinical decision‑making with real‑time physiological data.
Joeris General Contractors is a well‑established commercial construction firm founded in 1967 and based in Texas. The company provides general contracting and construction management services across a wide range of market sectors, including K‑12 schools, healthcare facilities, higher‑education buildings, retail spaces, industrial sites, and government projects. Joeris emphasizes trust‑based relationships with clients, architects, subcontractors, and employees, reflecting the principles established by its founder. Its service offerings span preconstruction planning, value analysis, project scheduling, construction execution, and commissioning. With multiple offices across Texas, Joeris has delivered numerous large‑scale projects and maintains a reputation for reliability, technical expertise, and on‑time, on‑budget project delivery.
